Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA

NCT ID: NCT03662607

Last Updated: 2025-03-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-18

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this study is to test the hypothesis that use of VR combined with standard procedural education will result in less pre-procedural anxiety than standard procedural education alone among patients undergoing first-time cardiac catheterization. The VR technology being evaluated in this study will allow patients to experience a 3-D simulation of certain aspects of their upcoming procedure prior to the actual procedure date.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preprocedure Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Standard pre-procedural education for cardiac catheterization.

Group Type NO_INTERVENTION

No interventions assigned to this group

Treatment

Standard pre-procedural education plus virtual reality experience for cardiac catheterization.

Group Type EXPERIMENTAL

Virtual reality experience

Intervention Type BEHAVIORAL

* Baseline wellness self-assessment administered (reporting on absence or presence and degree of severity of headache, nausea, dizziness, fatigue and vision abnormalities)
* Seated comfortably and free of direct obstruction
* Shown individual components of the VR system (View-Master with smartphone; headphones); given instructions; encouraged to ask questions.
* Begin the VR experience. Study personnel stay in the room \& provide guidance and answer questions regarding the technology
* When VR experience concluded, wellness self-assessment will be administered again.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual reality experience

* Baseline wellness self-assessment administered (reporting on absence or presence and degree of severity of headache, nausea, dizziness, fatigue and vision abnormalities)
* Seated comfortably and free of direct obstruction
* Shown individual components of the VR system (View-Master with smartphone; headphones); given instructions; encouraged to ask questions.
* Begin the VR experience. Study personnel stay in the room \& provide guidance and answer questions regarding the technology
* When VR experience concluded, wellness self-assessment will be administered again.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled to undergo a left-heart catheterization procedure at the Meijer Heart Center
* 18-75 years of age
* Signed study consent form

Exclusion Criteria

* History of cardiac procedure(s) in a cardiac catheterization laboratory
* History of seizures, migraine headaches or severe susceptibility to motion sickness
* Currently taking psychotropic drugs or on long-term psychotropic treatment
* Unable to read and speak English
* Visually impaired
* Unable to provide written consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Spectrum Health Hospitals

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ryan Madder, MD

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Spectrum Health

Grand Rapids, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-074

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

UHW Angiogram Video Project
NCT03957538 COMPLETED NA